Your browser doesn't support javascript.
loading
EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
Kolostyak, Zsuzsanna; Bojcsuk, Dora; Baksa, Viktoria; Szigeti, Zsuzsa Mathene; Bene, Krisztian; Czimmerer, Zsolt; Boto, Pal; Fadel, Lina; Poliska, Szilard; Halasz, Laszlo; Tzerpos, Petros; Berger, Wilhelm K; Villabona-Rueda, Andres; Varga, Zsofia; Kovacs, Tunde; Patsalos, Andreas; Pap, Attila; Vamosi, Gyorgy; Bai, Peter; Dezso, Balazs; Spite, Matthew; D'Alessio, Franco R; Szatmari, Istvan; Nagy, Laszlo.
Afiliación
  • Kolostyak Z; Department of Biochemistry and Molecular Biology, Faculty of Medicine.
  • Bojcsuk D; Doctoral School of Molecular Cell and Immune Biology; and.
  • Baksa V; Department of Biochemistry and Molecular Biology, Faculty of Medicine.
  • Szigeti ZM; Department of Molecular Biotechnology and Microbiology, Faculty of Science, University of Debrecen, Debrecen, Hungary.
  • Bene K; Department of Molecular Biotechnology and Microbiology, Faculty of Science, University of Debrecen, Debrecen, Hungary.
  • Czimmerer Z; Department of Biochemistry and Molecular Biology, Faculty of Medicine.
  • Boto P; Department of Biochemistry and Molecular Biology, Faculty of Medicine.
  • Fadel L; Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Szeged, Hungary.
  • Poliska S; Department of Biochemistry and Molecular Biology, Faculty of Medicine.
  • Halasz L; Department of Biophysics and Cell Biology, and.
  • Tzerpos P; Genomic Medicine and Bioinformatic Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Berger WK; Departments of Medicine and Biological Chemistry, Johns Hopkins University School of Medicine, Institute for Fundamental Biomedical Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
  • Villabona-Rueda A; Department of Biochemistry and Molecular Biology, Faculty of Medicine.
  • Varga Z; Departments of Medicine and Biological Chemistry, Johns Hopkins University School of Medicine, Institute for Fundamental Biomedical Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
  • Kovacs T; Division of Pulmonary Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Patsalos A; Department of Biochemistry and Molecular Biology, Faculty of Medicine.
  • Pap A; Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Szeged, Hungary.
  • Vamosi G; Department of Medical Chemistry and.
  • Bai P; Departments of Medicine and Biological Chemistry, Johns Hopkins University School of Medicine, Institute for Fundamental Biomedical Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
  • Dezso B; Department of Biochemistry and Molecular Biology, Faculty of Medicine.
  • Spite M; Department of Biophysics and Cell Biology, and.
  • D'Alessio FR; Department of Medical Chemistry and.
  • Szatmari I; Research Center for Molecular Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Nagy L; MTA-DE Cell Biology and Signaling Research Group ELKH, Debrecen, Hungary.
JCI Insight ; 9(17)2024 Sep 10.
Article en En | MEDLINE | ID: mdl-39042472
ABSTRACT
Alveolar macrophages (AMs) act as gatekeepers of the lung's immune responses, serving essential roles in recognizing and eliminating pathogens. The transcription factor (TF) early growth response 2 (EGR2) has been recently described as required for mature AMs in mice; however, its mechanisms of action have not been explored. Here, we identified EGR2 as an epigenomic regulator and likely direct proximal transcriptional activator in AMs using epigenomic approaches (RNA sequencing, ATAC sequencing, and CUT&RUN). The predicted direct proximal targets of EGR2 included a subset of AM identity genes and ones related to pathogen recognition, phagosome maturation, and adhesion, such as Clec7a, Atp6v0d2, Itgb2, Rhoc, and Tmsb10. We provided evidence that EGR2 deficiency led to impaired zymosan internalization and reduced the capacity to respond to Aspergillus fumigatus. Mechanistically, the lack of EGR2 altered the transcriptional response, secreted cytokines (i.e., CXCL11), and inflammation-resolving lipid mediators (i.e., RvE1) of AMs during in vivo zymosan-induced inflammation, which manifested in impaired resolution. Our findings demonstrated that EGR2 is a key proximal transcriptional activator and epigenomic bookmark in AMs responsible for select, distinct components of cell identity and a protective transcriptional and epigenomic program against fungi.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fagocitosis / Aspergillus fumigatus / Macrófagos Alveolares / Proteína 2 de la Respuesta de Crecimiento Precoz Límite: Animals Idioma: En Revista: JCI Insight Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fagocitosis / Aspergillus fumigatus / Macrófagos Alveolares / Proteína 2 de la Respuesta de Crecimiento Precoz Límite: Animals Idioma: En Revista: JCI Insight Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos